Literature DB >> 19516048

Powerful choices: peer support and individualized medication self-determination.

Corinna West1.   

Abstract

Mesh：

Year:  2009        PMID： 19516048      PMCID： PMC3080673          DOI： 10.1093/schbul/sbp053

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN： 0586-7614            Impact factor:   9.306


× No keyword cloud information.
  22 in total

1.  Comparing practice patterns of consumer and non-consumer mental health service providers.

Authors:  R Paulson; H Herinckx; J Demmler; G Clarke; D Cutler; E Birecree
Journal:  Community Ment Health J       Date:  1999-06

2.  Evidence-based practices and recovery.

Authors:  Daniel B Fisher; Laurie Ahern
Journal:  Psychiatr Serv       Date:  2002-05       Impact factor: 3.084

Review 3.  Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis.

Authors:  J Geddes; N Freemantle; P Harrison; P Bebbington
Journal:  BMJ       Date:  2000-12-02

4.  Clinical outcome of patients with schizophrenia without maintenance treatment in a nonindustrialized society.

Authors:  Toshiyuki Kurihara; Motoichiro Kato; Robert Reverger; Gohei Yagi
Journal:  Schizophr Bull       Date:  2002       Impact factor: 9.306

5.  Beyond generic support: incidence and impact of invalidation in peer services for clients with severe mental illness.

Authors:  Dave Sells; Ryan Black; Larry Davidson; Michael Rowe
Journal:  Psychiatr Serv       Date:  2008-11       Impact factor: 3.084

6.  Dopamine supersensitivity correlates with D2High states, implying many paths to psychosis.

Authors:  Philip Seeman; David Weinshenker; Remi Quirion; Lalit K Srivastava; Sanjeev K Bhardwaj; David K Grandy; Richard T Premont; Tatyana D Sotnikova; Patricia Boksa; Mufida El-Ghundi; Brian F O'dowd; Susan R George; Melissa L Perreault; Pekka T Männistö; Siobhan Robinson; Richard D Palmiter; Teresa Tallerico
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-16       Impact factor: 11.205

7.  The importance of personal medicine: a qualitative study of resilience in people with psychiatric disabilities.

Authors:  Patricia E Deegan
Journal:  Scand J Public Health Suppl       Date:  2005-10       Impact factor: 3.021

Review 8.  Empirical correction of seven myths about schizophrenia with implications for treatment.

Authors:  C M Harding; J H Zahniser
Journal:  Acta Psychiatr Scand Suppl       Date:  1994

9.  Clinical risk following abrupt and gradual withdrawal of maintenance neuroleptic treatment.

Authors:  A C Viguera; R J Baldessarini; J D Hegarty; D P van Kammen; M Tohen
Journal:  Arch Gen Psychiatry       Date:  1997-01

Review 10.  The case against antipsychotic drugs: a 50-year record of doing more harm than good.

Authors:  Robert Whitaker
Journal:  Med Hypotheses       Date:  2004       Impact factor: 1.538
View more
  3 in total

1.  Uses and abuses of recovery: implementing recovery-oriented practices in mental health systems.

Authors:  Mike Slade; Michaela Amering; Marianne Farkas; Bridget Hamilton; Mary O'Hagan; Graham Panther; Rachel Perkins; Geoff Shepherd; Samson Tse; Rob Whitley
Journal:  World Psychiatry       Date:  2014-02       Impact factor: 49.548

2.  Explaining attitudes and adherence to antipsychotic medication: the development of a process model.

Authors:  Martin Wiesjahn; Esther Jung; Fabian Lamster; Winfried Rief; Tania M Lincoln
Journal:  Schizophr Res Treatment       Date:  2014-02-19

3.  Psychiatric advance directives for people living with schizophrenia, bipolar I disorders, or schizoaffective disorders: Study protocol for a randomized controlled trial - DAiP study.

Authors:  Aurélie Tinland; Léa Leclerc; Sandrine Loubière; Frederic Mougeot; Tim Greacen; Magali Pontier; Nicolas Franck; Christophe Lançon; Mohamed Boucekine; Pascal Auquier
Journal:  BMC Psychiatry       Date:  2019-12-27       Impact factor: 3.630
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.